
The COVID-19 pandemic dramatically accelerated cancer-vaccine science by validating the mRNA technology at global scale.
Michelle Wang is an Analyst at Windrose Consulting Group in Philadelphia.

The COVID-19 pandemic dramatically accelerated cancer-vaccine science by validating the mRNA technology at global scale.